Literature DB >> 30329059

Host NAD+ metabolism and infections: therapeutic implications.

Amit Singhal1,2,3, Catherine Youting Cheng1.   

Abstract

Nicotinamide adenine dinucleotide (NAD+) is both a crucial coenzyme and a cosubstrate for various metabolic reactions in all living cells. Maintenance of NAD+ levels is essential for cell energy homeostasis, survival, proliferation and function. Mounting evidence points to NAD+ as one of the major modulators of immuno-metabolic circuits, thus regulating immune responses and functions. Recent studies delineate impaired host NAD+ metabolism during chronic infections and inflammation, suggesting NAD+ replenishment as an avenue to ameliorate deleterious inflammatory responses. Here, we discuss aspects of NAD+ biosynthesis and consumption, NAD+ biology during infections and how NAD+ metabolism can be intervened with pharmacologically to enhance the host's immunological fitness against pathogens. © The Japanese Society for Immunology. 2018. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  NAD+; bacteria; immunity; immuno-metabolism

Mesh:

Substances:

Year:  2019        PMID: 30329059     DOI: 10.1093/intimm/dxy068

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  9 in total

1.  Integrated Analysis of lncRNA and circRNA Mediated ceRNA Regulatory Networks in Skin Reveals Innate Immunity Differences Between Wild-Type and Yellow Mutant Rainbow Trout (Oncorhynchus mykiss).

Authors:  Shenji Wu; Jinqiang Huang; Yongjuan Li; Zhe Liu; Lu Zhao
Journal:  Front Immunol       Date:  2022-05-17       Impact factor: 8.786

Review 2.  Is nuclear sirtuin SIRT6 a master regulator of immune function?

Authors:  Vinodkumar B Pillai; Mahesh P Gupta
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-12-14       Impact factor: 4.310

Review 3.  A Novel NAD Signaling Mechanism in Axon Degeneration and its Relationship to Innate Immunity.

Authors:  Eleanor L Hopkins; Weixi Gu; Bostjan Kobe; Michael P Coleman
Journal:  Front Mol Biosci       Date:  2021-07-08

4.  Deciphering the co-adaptation of codon usage between respiratory coronaviruses and their human host uncovers candidate therapeutics for COVID-19.

Authors:  Komi Nambou; Manawa Anakpa
Journal:  Infect Genet Evol       Date:  2020-07-22       Impact factor: 3.342

Review 5.  Clinical Evidence for Targeting NAD Therapeutically.

Authors:  Dina Radenkovic; Eric Verdin
Journal:  Pharmaceuticals (Basel)       Date:  2020-09-15

Review 6.  The Prospective Synergy of Antitubercular Drugs With NAD Biosynthesis Inhibitors.

Authors:  Kyle H Rohde; Leonardo Sorci
Journal:  Front Microbiol       Date:  2021-01-26       Impact factor: 5.640

7.  TNB-738, a biparatopic antibody, boosts intracellular NAD+ by inhibiting CD38 ecto-enzyme activity.

Authors:  Harshad S Ugamraj; Kevin Dang; Laure-Hélène Ouisse; Benjamin Buelow; Eduardo N Chini; Giulia Castello; James Allison; Starlynn C Clarke; Laura M Davison; Roland Buelow; Rong Deng; Suhasini Iyer; Ute Schellenberger; Sankar N Manika; Shipra Bijpuria; Astrid Musnier; Anne Poupon; Maria Cristina Cuturi; Wim van Schooten; Pranjali Dalvi
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 6.440

Review 8.  Nicotinamide Riboside-The Current State of Research and Therapeutic Uses.

Authors:  Mario Mehmel; Nina Jovanović; Urs Spitz
Journal:  Nutrients       Date:  2020-05-31       Impact factor: 5.717

Review 9.  Nicotinamide adenine dinucleotide metabolism in the immune response, autoimmunity and inflammageing.

Authors:  Maria N Navarro; Manuel M Gómez de Las Heras; Maria Mittelbrunn
Journal:  Br J Pharmacol       Date:  2021-05-12       Impact factor: 9.473

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.